Companies Dominating the Aortic Aneurysm Landscape
- Medtronic
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- W. L. Gore & Associates, Inc.
- MicroPort Scientific Corporation
- Terumo Corporation
- Endologix LLC
- Boston Scientific Corporation
- Japan Lifeline Co., Ltd.
- Bentley InnoMed GmbH
The current dynamics of the aortic aneurysm market are following the trend of innovation and globalization. To participate in this cohort, key players in this field are increasingly expanding their territory in un-tapped or emerging landscapes. For instance, in May 2023, Therapeutic Solutions International formed a new subsidiary, VasoSome Vascular Inc., cultivating innovative AA treatments by utilizing stem cell–derived exosomes. Simultaneously, in August 2024, Terumo introduced its advanced solution for EVAR procedures, TREO Stent-Graft System, to the market in India. This remarkable device is capable of supporting both suprarenal and infrarenal active fixation, solidifying the company’s debut overseas. Such key players are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of aortic aneurysm is estimated at USD 5.84 billion.
The global aortic aneurysm market is likely to expand from USD 5.45 billion in 2024 to USD 19.49 billion by 2037, witnessing a CAGR of around 10.3% throughout the forecast period, between 2025 and 2037.
North America industry is likely to hold largest revenue share of 40% by 2037, due to rising presence of top-notch healthcare infrastructure along with constant technological progress in the medical industry.
The major players in the market include Medtronic, W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, Terumo Corporation, Endologix LLC, Boston Scientific Corporation, Japan Lifeline Co., Ltd.
